Dr Wen has 18 years of rich experience in translational medicine for cancer treatment in academia with extensive research in tumor biology, cancer immunology, cancer metabolism, drug screening, biomarker discovery and etc. As a principal investigator in Robert Wood Johnson Medical School in US, she published many research papers focusing on tumor immunology, especially the mechanism of therapeutic resistance of immune checkpoint blockers. Some of her works were supported by NIH grant. Dr Wen received her Ph.D. from Pennsylvania State University and postdoctoral fellow from Robert Wood Johnson Medical School in US.
Dr Wen has 18 years of rich experience in translational medicine for cancer treatment in academia with extensive research in tumor biology, cancer immunology, cancer metabolism, drug screening, biomarker discovery and etc. As a principal investigator in Robert Wood Johnson Medical School in US, she published many research papers focusing on tumor immunology, especially the mechanism of therapeutic resistance of immune checkpoint blockers. Some of her works were supported by NIH grant. Dr Wen received her Ph.D. from Pennsylvania State University and postdoctoral fellow from Robert Wood Johnson Medical School in US.
粤公网安备 44030902003233号